Navigation Links
Astellas and Gift of Hope Organ & Tissue Donor Network Join Forces to Raise Awareness of Need for More Organ Donors in Chicago
Date:4/19/2013

NORTHBROOK, Ill., April 19, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), and Gift of Hope Organ & Tissue Donor Network, a not-for-profit organ procurement organization that coordinates organ and tissue donation and provides public education on donation in Illinois and northwest Indiana, have collaborated to raise awareness of the need for more organ donors in the city of Chicago. As part of the efforts, Mayor Rahm Emanuel signed a proclamation declaring today, April 19, Organ Donation Awareness Day in the city of Chicago. Astellas and Gift of Hope are encouraging the Chicago community to learn more about organ donation, and register their decision to donate.

"We're proud to partner with Astellas in building a community of support around organ donation awareness and the need for more donors," said David Bosch , Director of Communications and Legislative Affairs at Gift of Hope. "The decision to be an organ donor gives hope to many people awaiting a second chance."

While organ transplantation is a remarkable story in the history of medicine, the need for organs is vastly greater than the number available for transplantation. Currently there are more than 117,000 people in the U.S. awaiting an organ transplant – including more than 5,000 people in Illinois. Each year, more than 28,000 Americans receive a donated organ, but sadly, more than 6,500 people die each year waiting for an organ.

Today's proclamation underscores Astellas' ongoing commitment to the Chicago community, as well as the national tran
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure
2. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
3. PGA TOUR Celebrates Official Launch of the Astellas Presents Executive Womens Day Program
4. Astellas to Drive PGA TOURs New Womens Initiative
5. Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
6. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
7. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
8. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
9. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
10. Astellas and Fujita Health University Discover Neuronal Maturation Deficits in Patients Suffering from Schizophrenia and Bipolar Disorder
11. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 Sangamo BioSciences, Inc. (NASDAQ: ... release its second quarter 2015 financial results after the ... release will be followed by a conference call at ... public via telephone and webcast. During the conference call, ... discuss other business matters. The conference call ...
(Date:7/29/2015)... 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... up to $21.5 million through two financing agreements. The ... ) ("Hercules"), for a term loan of up to ... Growth Fund ("Discover"), for the sale to Discover of ... Stock") for up to $12 million in gross proceeds ...
(Date:7/29/2015)... Washington , 29 luglio 2015 ... ha scoperto che l,ingestione quotidiana del probiotico ... intestinale umano e modifica la produzione intestinale di ... studio riguardava la somministrazione quotidiana di ceppo di ... SD-5865) in compresse utilizzando il sistema di somministrazione ...
Breaking Medicine Technology:Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2
... Dystrophy Association announced today that SMT C1100, an experimental ... received approval from regulatory agencies in the United Kingdom ... healthy human volunteers. (Logo: http://photos.prnewswire.com/prnh/20120424/DC93207LOGO ) ... of a muscle protein utrophin that can potentially compensate ...
... Argos Therapeutics Inc. today announced that it has ... the commencement of its Phase 3 ADAPT study in ... in mid-2012. The financing was led by Forbion Capital ... Capital, Intersouth Partners, Caisse de depot et placement du ...
Cached Medicine Technology:SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing 2SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing 3Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012 2Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012 3
(Date:7/30/2015)... ... 30, 2015 , ... PeopleKeys, a company with over 30 years of experience ... webinar. The webinar, the newest installment in their popular DISC for the Real World ... Train the Trainer webinar is intended for people interested in training others to use ...
(Date:7/29/2015)... , ... July 30, 2015 , ... Avid collector, Andrew ... Arena Raleigh North Carolina concert posters. The same poster art was used for the ... Globe Poster based in Baltimore and are classic boxing style concert posters. , ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to data released today ... D premium is expected to remain stable at $32.50, a figure far lower than ... D program continues to be a bright spot in American health care. By offering ...
(Date:7/29/2015)... Michigan (PRWEB) , ... July 29, 2015 , ... Sports ... treated to a visit by former players of the Detroit Lions, joined by A ... July 10th, 2015 Pro Bowl Wide Receiver Herman Moore, Pro Bowl Offensive Lineman Lomas ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... This past ... a positive surrogacy journey from a treasured member of the CARE extended family. ... Vallarta hopes to help intended parents across the globe gain a newfound perspective on ...
Breaking Medicine News(10 mins):Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:A Forever Recovery Holds Autograph Event with Former Detroit Lions at Cherry Festival 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3
... A new research conducted by Derek Griffiths, Ph.D., professor of ... poor bladder// control is due to the reduced activity of ... reported his findings in a recent issue of the Journal ... imaging (fMRI) technology. , He analyzed the brain ...
... is reported to have died after a general practitioner had ... had displayed obvious symptoms of meningitis like a sore neck. ... when her condition deteriorated. Even at the hospital the case ... girl developing rashes. The treatment given to the girl was ...
... progress made with regard to a ten-year-old plan to scale ... the poor// and the rich with regard to this however ... 2000, with the establishment of 34 networks for providing better ... to cancer. ,Improvements have been made with ...
... researchers which is responsible for over 20% of the ... Arabs.// It was previously believed that genetics had a ... particular mutation is quite rare where people living outside ... responsible for the incidences of Parkinson’s disease beyond this ...
... Thomas Sandstrom, Respiratory Medicine and Allergy, University Hospital, Sweden ... to diesel exhaust increased inflammation response in the lungs ... in the airway pathways and openings and when they ... the airway they found a decreased inflammatory cells which ...
... Keith Palmer and his team from Southampton General Hospital, ... workers.// The research work is aimed at studying the ... occupational exposure to metal fume. ,Researchers found ... be low compared to the normal persons and an ...
Cached Medicine News:Health News:Parkinson's Disease Has Genetic Roots 2
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Classic proven design with superior clinical results....
Dual offset femoral stems, hip stems that provide unique and competitive features....
The Perfecta RS Stems utilize the same proven proximal Tri/Planar wedge geometry, medial flare options and proximal coatings of the Perfecta Plasma Spray Stems....
Medicine Products: